Related Experiment Videos
Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice
The Journal of Clinical Psychiatry
|October 1, 1985
Summary
This review covers tricyclic antidepressants (TCAs), focusing on nortriptyline pharmacokinetics. It highlights using plasma levels for effective dosing and minimizing side effects in diverse patient groups.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Psychopharmacology
Background:
- Tricyclic antidepressants (TCAs) are a cornerstone in treating various conditions.
- Understanding their pharmacokinetics is crucial for optimizing patient outcomes.
- Nortriptyline serves as a key model due to extensive research.
Purpose of the Study:
- To review the pharmacokinetics of TCAs, with a focus on nortriptyline.
- To discuss the clinical application of TCA plasma level-response studies.
- To provide guidance on rational dosage adjustment for improved efficacy and safety.
Main Methods:
- Literature review of pharmacokinetic studies on TCAs.
- Analysis of plasma level-response data for nortriptyline.
- Synthesis of information regarding active metabolites and predictive studies.
Main Results:
- Nortriptyline exhibits well-characterized pharmacokinetics, making it ideal for study.
- Plasma TCA levels correlate with therapeutic response and toxicity.
- Active metabolites can influence overall drug effect.
Conclusions:
- Plasma level-monitoring enables rational TCA dosage adjustment.
- Optimizing TCA therapy can enhance response rates and reduce iatrogenic toxicity.
- Special populations, including the elderly and medically ill, require tailored treatment approaches.